[22] The existence of rare case reports of kidney failure and hypersensitivity reactions is noted in the United States prescribing information, but a causative role for sitagliptin has not been established
Insulin GLP-1 RA Pen References: Pyrls, pyrls.com (Login required) Accessed 12/04/2025
This trial led the FDA to expand Wegovy's label to include reducing cardiovascular risk in people with obesity
You probably won't experience meaningful appetite reduction until you've been taking the medication for 4-8 weeks or more and reach a higher dose
For example, studies show that soluble fiber can lower blood sugar and cholesterol levels, increase feelings of fullness to support weight loss, and help protect against certain types of cancer ( summary Citrucel can reduce symptoms of constipation
However, a number of challenges will need to be addressed over next years including a better understanding of the full potential of benefits and risks with the new obesity pharmacotherapies and ensuring wide and equal access for people living with obesity
